Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RadLink is a leading private diagnostic and molecular imaging service provider based in Singapore, specializing in the production and clinical application of radiopharmaceuticals. Founded in 2000, the company operates a comprehensive network of diagnostic imaging centers and a specialized radiopharmaceutical manufacturing facility, Singapore Radiopharmaceuticals (SRP), which is the only facility in the country capable of producing Carbon-11 and Fluorine-18 isotopes. RadLink serves as the exclusive manufacturer and supplier of GE Healthcare's Vizamyl (flutemetamol F18) in Singapore, a key imaging agent for the early detection of Alzheimer's disease. The company provides a wide array of PET and SPECT tracers for oncology, neurology, and cardiology, supporting both routine clinical diagnostics and advanced pharmaceutical research and development through its GMP-certified facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radlink.